期刊文献+

不同方法制备的1型肺炎球菌多糖-蛋白结合疫苗生化及免疫学特性比较 被引量:5

Biochemical and Immunological Characteristics of Pneumococcus Type 1 Conjugate Vaccine Prepared by Cyanogen Bromide Activation and Amine Reduction
下载PDF
导出
摘要 目的对两种方法制备1型肺炎球菌荚膜多糖-蛋白结合疫苗的生化及免疫学特性进行比较。方法分别采用溴化氰活化法与胺还原法制备结合物,并对其进行生化及免疫学检测。结果采用溴化氰活化法制备的结合物,较胺还原法具有较高的结合率及高分子结合物含量,免疫小鼠产生的抗体效价较胺还原法明显提高。结论采用溴化氰活化法制备1型肺炎球菌荚膜多糖-蛋白结合疫苗优于胺还原法。 Objective To compare the biochemical and immunological characteristics of pneumococcus type 1 conjugate vaccine prepared by cyanogen bromide activation and amine reduction. Methods Prepare pneumococcus type 1 conjugate vaccine by cyanogen bromide activation and amine reduction respectively and determine their biochemical and immunological characteristics. Results The conjugation rate, high molecular conjugate content of and the antibody titer induced with pneumococcus type 1 conjugate vaccine prepared by cyanogen bromide activation were significantly higher than that by amine reduction. Conclusion Compared with amine reduction, cyanogen bromide activation was more suitable for the preparation of pneumococcus type 1 conjugate vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2007年第5期369-371,共3页 Chinese Journal of Biologicals
关键词 溴化氰活化法 胺还原法 结合疫苗 生化特性 免疫学特性 Cyanogen bromide activation Amine reduction Conjugate vaccine Biochemical characteristic Immunological characteristic
  • 相关文献

参考文献7

  • 1Robbins JB,Schneerson R,Shousun CZ.Perspective hypothesis:serum IgG antibody is sufficien to confer protection against infections diseases by inactivating theinoculum.J Infect Dis,1995,171(6):1387-1398.
  • 2Kuo J,Douglas M,Kimree H,et al.Characterization of a recombinant pneumolysin and its use as a protein carrier for pneumococcal type 18C conjugate vaccines.Infect Immun,1995,63(7):2706-2713.
  • 3Bitter T,Muir HM.A modified uronic acid carbazole reaction.Ana Biochem,1962,4(4):330-334.
  • 4Guo YY,Anderson R,Mclver J,et al.A simple and rapid method for measuring unconjugated capsular polysaccaride(PRP) of Haemophilus influenzae type b in PRP-tetanas toxoid conjugate vaccine.Biologicals,1998,26(1):33-38.
  • 5Andre J.Immunology of bacterial polysaccharide antigens.Carbohydrat Res,2003,338(23):2539-2547.
  • 6Black SB,Shinefield HR,Ling S,et al.Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia.Pediatr Infect Dis J,2002,21(9):810-815.
  • 7O'Brien KL,Moulton LH,Reid R,et al.Efficacy and safety of seven valent conjugate pneumococcal vaccine in American Indian Children:Group randomized trial.Lancet,2003,362(9381):355-361.

同被引文献86

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部